Related references
Note: Only part of the references are listed.Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus
Kyoung-Dong Kim et al.
NATURE COMMUNICATIONS (2020)
Epigenetic lifestyle of Epstein-Barr virus
Alexander Buschle et al.
SEMINARS IN IMMUNOPATHOLOGY (2020)
A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis
Akshaya Ramesh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
B lymphocytes: Crucial contributors to brain development and neurological diseases
Shogo Tanabe et al.
NEUROSCIENCE RESEARCH (2019)
Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth
Troy E. Messick et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection
Paulina Mrozek-Gorska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The Global Landscape of EBV-Associated Tumors
Claire Shannon-Lowe et al.
FRONTIERS IN ONCOLOGY (2019)
Epithelial cell infection by Epstein-Barr virus
Jia Chen et al.
FEMS MICROBIOLOGY REVIEWS (2019)
B cells in autoimmune and neurodegenerative central nervous system diseases
Joseph J. Sabatino et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Transcription Factor T-bet in B Cells Modulates Germinal Center Polarization and Antibody Affinity Maturation in Response to Malaria
Ann Ly et al.
CELL REPORTS (2019)
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers
Olaf Stuve et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis
Caterina Veroni et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity
John B. Harley et al.
NATURE GENETICS (2018)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
Elmira Agah et al.
PLOS ONE (2018)
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis
Michael P. Pender et al.
JCI INSIGHT (2018)
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Tomas Olsson et al.
NATURE REVIEWS NEUROLOGY (2017)
Ocrelizumab: a B-cell depleting therapy for multiple sclerosis
Dejan Jakimovski et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
B cells expressing the transcription factor T-bet drive lupus-like autoimmunity
Kira Rubtsova et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Evolving concepts in the treatment of relapsing multiple sclerosis
Giancarlo Comi et al.
LANCET (2017)
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
Daniel Ontaneda et al.
LANCET (2017)
Diagnosis of multiple sclerosis: progress and challenges
Wallace J. Brownlee et al.
LANCET (2017)
Primary central nervous system lymphoma: essential points in diagnosis and management
Semra Paydas
MEDICAL ONCOLOGY (2017)
GeneHancer: genome-wide integration of enhancers and target genes in GeneCards
Simon Fishilevich et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2017)
EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency
Christine T. Styles et al.
PLOS BIOLOGY (2017)
Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis
Martin Laurence et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
EBV and MS: Major cause, minor contribution or red -herring?
Sean Burnard et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients
Erica L. Eggers et al.
JCI INSIGHT (2017)
Both cladribine and alemtuzumab may effect MS via B-cell depletion
David Baker et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies
Santiago Fernandez-Menendez et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Multiple sclerosis and related disorders: evolving pathophysiologic insights
Amit Bar-Or
LANCET NEUROLOGY (2016)
The osteopontin transgenic mouse is a new model for Sjogren's syndrome
Sehba Husain-Krautter et al.
CLINICAL IMMUNOLOGY (2015)
Osteopontin in Immune-mediated Diseases
S. R. Rittling et al.
JOURNAL OF DENTAL RESEARCH (2015)
Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis
Catherina Pfuhl et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Epstein-Barr Virus Infection and Gastric Cancer A Systematic Review
Xin-Zu Chen et al.
MEDICINE (2015)
The ins and outs of B cells in multiple sclerosis
Kevin Blauth et al.
FRONTIERS IN IMMUNOLOGY (2015)
Host genetics of Epstein-Barr virus infection, latency and disease
Charlotte J. Houldcroft et al.
REVIEWS IN MEDICAL VIROLOGY (2015)
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma
Chen Lossos et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL)
Anna Sophie Berghoff et al.
CLINICAL NEUROPATHOLOGY (2014)
Osteopontin as a therapeutic target for cancer
Monalisa Bandopadhyay et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Increased Circulating Th17 Cell Populations and Elevated CSF Osteopontin and IL-17 Concentrations in Patients with Guillain-Barr, Syndrome
Rong kun Han et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Epstein-Barr Virus in the Central Nervous System and Cervical Lymph Node of a Patient With Primary Progressive Multiple Sclerosis
Barbara Serafini et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
Joel N. H. Stern et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain
Barbara Serafini et al.
BRAIN (2013)
Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis
Emilia Carlsson et al.
GENES CHROMOSOMES & CANCER (2013)
Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression
Ji Yuan et al.
HUMAN PATHOLOGY (2013)
The Epstein-Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins
Giuseppe Coppotelli et al.
NUCLEIC ACIDS RESEARCH (2013)
The pathogenesis of Epstein-Barr virus persistent infection
David A. Thorley-Lawson et al.
CURRENT OPINION IN VIROLOGY (2013)
Epigenetic control of Epstein–Barr virus transcription – relevance to viral life cycle?
Alison J. Sinclair
Frontiers in Genetics (2013)
B cell exchange across the blood-brain barrier in multiple sclerosis
H. -Christian von Buedingen et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Persistence of Epstein-Barr Virus in Self-Reactive Memory B Cells
Sean I. Tracy et al.
JOURNAL OF VIROLOGY (2012)
Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity
Anatoly V. Rubtsov et al.
BLOOD (2011)
Epstein-Barr virus in the multiple sclerosis brain: a controversial issue-report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria
Hans Lassmann et al.
BRAIN (2011)
The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
Michael P. Pender
NEUROSCIENTIST (2011)
Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection
Claire Shannon-Lowe et al.
PLOS PATHOGENS (2011)
Controversial Role of Epstein-Barr Virus in Multiple Sclerosis
Nazneen Fatima et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2011)
An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
Adam E. Handel et al.
PLOS ONE (2010)
Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection
Michael P. Pender
AUTOIMMUNITY REVIEWS (2009)
Shifting therapeutic attention in MS to osteopontin, type 1 and type 2 IFN
Lawrence Steinman
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Mammalian Navigators are Microtubule Plus-End Tracking Proteins that can Reorganize the Cytoskeleton to Induce Neurite-Like Extensions
Jeffrey van Haren et al.
CELL MOTILITY AND THE CYTOSKELETON (2009)
The role of osteopontin in inflammatory processes
Susan Amanda Lund et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Increased Osteopontin Expression in Dendritic Cells Amplifies IL-17 Production by CD4+ T Cells in Experimental Autoimmune Encephalomyelitis and in Multiple Sclerosis
Gopal Murugaiyan et al.
JOURNAL OF IMMUNOLOGY (2008)
Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality
David A. Thorley-Lawson et al.
TRENDS IN IMMUNOLOGY (2008)
Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1
Justine R. Smith et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells
Eun Mi Hur et al.
NATURE IMMUNOLOGY (2007)
Increased frequency and broadened specificity of latent EBV nuclear antigen-I-specific T cells in multiple sclerosis
Jan D. Lunemann et al.
BRAIN (2006)
Epstein-Barr virus and multiple sclerosis - Evidence of association from a prospective study with long-term follow-up
Gerald N. DeLorenze et al.
ARCHIVES OF NEUROLOGY (2006)
T-bet-dependent expression of osteopontin contributes to T cell polarization
ML Shinohara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression
A Chiocchetti et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis
LI Levin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients
MHJ Vogt et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Osteopontin polymorphisms and disease course in multiple sclerosis
S Caillier et al.
GENES AND IMMUNITY (2003)
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
SM Tugizov et al.
NATURE MEDICINE (2003)
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases
MP Pender
TRENDS IN IMMUNOLOGY (2003)
Neuron navigator:: A human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans
T Maes et al.
GENOMICS (2002)
T-bet regulates IgG class switching and pathogenic autoantibody production
SL Peng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Epstein-Barr virus antibodies and risk of multiple sclerosis -: A prospective study
A Ascherio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas et al.
SCIENCE (2001)
Epstein-Barr virus infection.
JI Cohen
NEW ENGLAND JOURNAL OF MEDICINE (2000)
A novel transcription factor, T-bet, directs Th1 lineage commitment
SJ Szabo et al.
CELL (2000)
Primary intracerebral malignant lymphoma: report of 248 cases
B Bataille et al.
JOURNAL OF NEUROSURGERY (2000)
Share Paper
